You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

  • Technology appraisal guidance
  • Reference number: TA275
  • Published:  27 February 2013
  • Last updated:  02 July 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: patient group, professional and NHS organisation submission statements

  • Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: AntiCoagulant Europe

  • Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Arrhythmia Alliance

  • Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Clinical Leader of Thrombosis

  • Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Heart Rhythm UK

  • Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Royal College of Nursing

  • Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Royal College of Physicians and British Society of Haematology


This page was last updated: 20 March 2014

Back to top